Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States Article Swipe

PDF

Yan Wang , Imad Al‐Dakkak , Katherine Garlo , Moh‐Lim Ong , Ioannis Tomazos , Arash Mahajerin ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1016/j.xkme.2023.100683

Related Topics

Concepts

Eculizumab Atypical hemolytic uremic syndrome Medicine Intensive care medicine Pediatrics Immunology Antibody Complement system

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.xkme.2023.100683
PDF: http://www.kidneymedicinejournal.org/article/S2590059523000997/pdf
OA Status: gold
Cited By: 7
References: 44
Related Works: 10
OpenAlex ID: https://openalex.org/W4378901802

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4378901802

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.xkme.2023.100683

Digital Object Identifier
Title: Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-05-31

Full publication date if available
Authors: Yan Wang, Imad Al‐Dakkak, Katherine Garlo, Moh‐Lim Ong, Ioannis Tomazos, Arash Mahajerin

List of authors in order
Landing page: https://doi.org/10.1016/j.xkme.2023.100683

Publisher landing page
PDF URL: https://www.kidneymedicinejournal.org/article/S2590059523000997/pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://www.kidneymedicinejournal.org/article/S2590059523000997/pdf

Direct OA link when available
Concepts: Eculizumab, Atypical hemolytic uremic syndrome, Medicine, Intensive care medicine, Pediatrics, Immunology, Antibody, Complement system

Top concepts (fields/topics) attached by OpenAlex
Cited by: 7

Total citation count in OpenAlex
Citations by year (recent): 2025: 3, 2024: 4

Per-year citation counts (last 5 years)
References (count): 44

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4378901802
doi	https://doi.org/10.1016/j.xkme.2023.100683
ids.doi	https://doi.org/10.1016/j.xkme.2023.100683
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/37415624
ids.openalex	https://openalex.org/W4378901802
fwci	1.35755808
type	article
title	Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States
biblio.issue	8
biblio.volume	5
biblio.last_page	100683
biblio.first_page	100683
topics[0].id	https://openalex.org/T10993
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	0.9998999834060669
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	Complement system in diseases
topics[1].id	https://openalex.org/T11193
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9822999835014343
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1314
topics[1].subfield.display_name	Physiology
topics[1].display_name	Adenosine and Purinergic Signaling
topics[2].id	https://openalex.org/T11029
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.978600025177002
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2727
topics[2].subfield.display_name	Nephrology
topics[2].display_name	Renal Diseases and Glomerulopathies
funders[0].id	https://openalex.org/F4320314126
funders[0].ror
funders[0].display_name	PTC Therapeutics
is_xpac	False
apc_list.value	2400
apc_list.currency	USD
apc_list.value_usd	2400
apc_paid.value	2400
apc_paid.currency	USD
apc_paid.value_usd	2400
concepts[0].id	https://openalex.org/C2777991916
concepts[0].level	4
concepts[0].score	0.9516674280166626
concepts[0].wikidata	https://www.wikidata.org/wiki/Q421617
concepts[0].display_name	Eculizumab
concepts[1].id	https://openalex.org/C2777637130
concepts[1].level	4
concepts[1].score	0.6928390860557556
concepts[1].wikidata	https://www.wikidata.org/wiki/Q17165460
concepts[1].display_name	Atypical hemolytic uremic syndrome
concepts[2].id	https://openalex.org/C71924100
concepts[2].level	0
concepts[2].score	0.5931004881858826
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[2].display_name	Medicine
concepts[3].id	https://openalex.org/C177713679
concepts[3].level	1
concepts[3].score	0.5268815159797668
concepts[3].wikidata	https://www.wikidata.org/wiki/Q679690
concepts[3].display_name	Intensive care medicine
concepts[4].id	https://openalex.org/C187212893
concepts[4].level	1
concepts[4].score	0.351630836725235
concepts[4].wikidata	https://www.wikidata.org/wiki/Q123028
concepts[4].display_name	Pediatrics
concepts[5].id	https://openalex.org/C203014093
concepts[5].level	1
concepts[5].score	0.26104605197906494
concepts[5].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[5].display_name	Immunology
concepts[6].id	https://openalex.org/C159654299
concepts[6].level	2
concepts[6].score	0.1932680904865265
concepts[6].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[6].display_name	Antibody
concepts[7].id	https://openalex.org/C111684460
concepts[7].level	3
concepts[7].score	0.10733932256698608
concepts[7].wikidata	https://www.wikidata.org/wiki/Q334848
concepts[7].display_name	Complement system
keywords[0].id	https://openalex.org/keywords/eculizumab
keywords[0].score	0.9516674280166626
keywords[0].display_name	Eculizumab
keywords[1].id	https://openalex.org/keywords/atypical-hemolytic-uremic-syndrome
keywords[1].score	0.6928390860557556
keywords[1].display_name	Atypical hemolytic uremic syndrome
keywords[2].id	https://openalex.org/keywords/medicine
keywords[2].score	0.5931004881858826
keywords[2].display_name	Medicine
keywords[3].id	https://openalex.org/keywords/intensive-care-medicine
keywords[3].score	0.5268815159797668
keywords[3].display_name	Intensive care medicine
keywords[4].id	https://openalex.org/keywords/pediatrics
keywords[4].score	0.351630836725235
keywords[4].display_name	Pediatrics
keywords[5].id	https://openalex.org/keywords/immunology
keywords[5].score	0.26104605197906494
keywords[5].display_name	Immunology
keywords[6].id	https://openalex.org/keywords/antibody
keywords[6].score	0.1932680904865265
keywords[6].display_name	Antibody
keywords[7].id	https://openalex.org/keywords/complement-system
keywords[7].score	0.10733932256698608
keywords[7].display_name	Complement system
language	en
locations[0].id	doi:10.1016/j.xkme.2023.100683
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210206143
locations[0].source.issn	2590-0595
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2590-0595
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Kidney Medicine
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].source.host_organization_lineage_names	Elsevier BV
locations[0].license
locations[0].pdf_url	http://www.kidneymedicinejournal.org/article/S2590059523000997/pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Kidney Medicine
locations[0].landing_page_url	https://doi.org/10.1016/j.xkme.2023.100683
locations[1].id	pmid:37415624
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Kidney medicine
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/37415624
locations[2].id	pmh:oai:pubmedcentral.nih.gov:10319830
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S2764455111
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	PubMed Central
locations[2].source.host_organization	https://openalex.org/I1299303238
locations[2].source.host_organization_name	National Institutes of Health
locations[2].source.host_organization_lineage	https://openalex.org/I1299303238
locations[2].license	cc-by-nc-nd
locations[2].pdf_url	https://pmc.ncbi.nlm.nih.gov/articles/PMC10319830/pdf/main.pdf
locations[2].version	submittedVersion
locations[2].raw_type	Text
locations[2].license_id	https://openalex.org/licenses/cc-by-nc-nd
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	Kidney Med
locations[2].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/10319830
locations[3].id	pmh:oai:doaj.org/article:d96dad70c99c410db6d13b5d7550d5da
locations[3].is_oa	False
locations[3].source.id	https://openalex.org/S4306401280
locations[3].source.issn
locations[3].source.type	repository
locations[3].source.is_oa	False
locations[3].source.issn_l
locations[3].source.is_core	False
locations[3].source.is_in_doaj	False
locations[3].source.display_name	DOAJ (DOAJ: Directory of Open Access Journals)
locations[3].source.host_organization
locations[3].source.host_organization_name
locations[3].license
locations[3].pdf_url
locations[3].version	submittedVersion
locations[3].raw_type	article
locations[3].license_id
locations[3].is_accepted	False
locations[3].is_published	False
locations[3].raw_source_name	Kidney Medicine, Vol 5, Iss 8, Pp 100683- (2023)
locations[3].landing_page_url	https://doaj.org/article/d96dad70c99c410db6d13b5d7550d5da
indexed_in	crossref, doaj, pubmed
authorships[0].author.id	https://openalex.org/A5100322813
authorships[0].author.orcid	https://orcid.org/0000-0002-8150-5486
authorships[0].author.display_name	Yan Wang
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210150756
authorships[0].affiliations[0].raw_affiliation_string	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[0].institutions[0].id	https://openalex.org/I4210150756
authorships[0].institutions[0].ror	https://ror.org/043cec594
authorships[0].institutions[0].type	company
authorships[0].institutions[0].lineage	https://openalex.org/I105036370, https://openalex.org/I4210150756
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	AstraZeneca (United States)
authorships[0].author_position	first
authorships[0].raw_author_name	Yan Wang
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[1].author.id	https://openalex.org/A5077739374
authorships[1].author.orcid	https://orcid.org/0000-0002-0804-998X
authorships[1].author.display_name	Imad Al‐Dakkak
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210150756
authorships[1].affiliations[0].raw_affiliation_string	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[1].institutions[0].id	https://openalex.org/I4210150756
authorships[1].institutions[0].ror	https://ror.org/043cec594
authorships[1].institutions[0].type	company
authorships[1].institutions[0].lineage	https://openalex.org/I105036370, https://openalex.org/I4210150756
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	AstraZeneca (United States)
authorships[1].author_position	middle
authorships[1].raw_author_name	Imad Al-Dakkak
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[2].author.id	https://openalex.org/A5064368770
authorships[2].author.orcid
authorships[2].author.display_name	Katherine Garlo
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210150756
authorships[2].affiliations[0].raw_affiliation_string	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[2].institutions[0].id	https://openalex.org/I4210150756
authorships[2].institutions[0].ror	https://ror.org/043cec594
authorships[2].institutions[0].type	company
authorships[2].institutions[0].lineage	https://openalex.org/I105036370, https://openalex.org/I4210150756
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	AstraZeneca (United States)
authorships[2].author_position	middle
authorships[2].raw_author_name	Katherine Garlo
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[3].author.id	https://openalex.org/A5112827953
authorships[3].author.orcid
authorships[3].author.display_name	Moh‐Lim Ong
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210150756
authorships[3].affiliations[0].raw_affiliation_string	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[3].institutions[0].id	https://openalex.org/I4210150756
authorships[3].institutions[0].ror	https://ror.org/043cec594
authorships[3].institutions[0].type	company
authorships[3].institutions[0].lineage	https://openalex.org/I105036370, https://openalex.org/I4210150756
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	AstraZeneca (United States)
authorships[3].author_position	middle
authorships[3].raw_author_name	Moh-Lim Ong
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[4].author.id	https://openalex.org/A5038346531
authorships[4].author.orcid	https://orcid.org/0000-0003-0290-4583
authorships[4].author.display_name	Ioannis Tomazos
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210150756
authorships[4].affiliations[0].raw_affiliation_string	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[4].institutions[0].id	https://openalex.org/I4210150756
authorships[4].institutions[0].ror	https://ror.org/043cec594
authorships[4].institutions[0].type	company
authorships[4].institutions[0].lineage	https://openalex.org/I105036370, https://openalex.org/I4210150756
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	AstraZeneca (United States)
authorships[4].author_position	middle
authorships[4].raw_author_name	Ioannis Tomazos
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Alexion, AstraZeneca Rare Disease, Boston, MA
authorships[5].author.id	https://openalex.org/A5035173382
authorships[5].author.orcid	https://orcid.org/0000-0002-0549-0155
authorships[5].author.display_name	Arash Mahajerin
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I1304278710
authorships[5].affiliations[0].raw_affiliation_string	Children's Health of Orange County Hospital, Orange, CA
authorships[5].institutions[0].id	https://openalex.org/I1304278710
authorships[5].institutions[0].ror	https://ror.org/0282qcz50
authorships[5].institutions[0].type	healthcare
authorships[5].institutions[0].lineage	https://openalex.org/I1304278710
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	Children's Hospital of Orange County
authorships[5].author_position	last
authorships[5].raw_author_name	Arash Mahajerin
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Children's Health of Orange County Hospital, Orange, CA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	http://www.kidneymedicinejournal.org/article/S2590059523000997/pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10993
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	0.9998999834060669
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	Complement system in diseases
related_works	https://openalex.org/W2765109318, https://openalex.org/W3095435819, https://openalex.org/W3031312213, https://openalex.org/W2341439572, https://openalex.org/W3104460379, https://openalex.org/W2565202172, https://openalex.org/W4226173199, https://openalex.org/W2077986770, https://openalex.org/W2072874604, https://openalex.org/W2141534367
cited_by_count	7
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	3
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	4
locations_count	4
best_oa_location.id	doi:10.1016/j.xkme.2023.100683
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210206143
best_oa_location.source.issn	2590-0595
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2590-0595
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Kidney Medicine
best_oa_location.source.host_organization	https://openalex.org/P4310320990
best_oa_location.source.host_organization_name	Elsevier BV
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320990
best_oa_location.source.host_organization_lineage_names	Elsevier BV
best_oa_location.license
best_oa_location.pdf_url	http://www.kidneymedicinejournal.org/article/S2590059523000997/pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Kidney Medicine
best_oa_location.landing_page_url	https://doi.org/10.1016/j.xkme.2023.100683
primary_location.id	doi:10.1016/j.xkme.2023.100683
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210206143
primary_location.source.issn	2590-0595
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2590-0595
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Kidney Medicine
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.source.host_organization_lineage_names	Elsevier BV
primary_location.license
primary_location.pdf_url	http://www.kidneymedicinejournal.org/article/S2590059523000997/pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Kidney Medicine
primary_location.landing_page_url	https://doi.org/10.1016/j.xkme.2023.100683
publication_date	2023-05-31
publication_year	2023
referenced_works	https://openalex.org/W3011290754, https://openalex.org/W2159884188, https://openalex.org/W2098383030, https://openalex.org/W2149943632, https://openalex.org/W2106675927, https://openalex.org/W2158943356, https://openalex.org/W2305176160, https://openalex.org/W2017235356, https://openalex.org/W2118510193, https://openalex.org/W2264090971, https://openalex.org/W2966342106, https://openalex.org/W6806888792, https://openalex.org/W6784108493, https://openalex.org/W2797057269, https://openalex.org/W3009429865, https://openalex.org/W3138689598, https://openalex.org/W4242833177, https://openalex.org/W3202358903, https://openalex.org/W3091806808, https://openalex.org/W3009860442, https://openalex.org/W3184649349, https://openalex.org/W6803593755, https://openalex.org/W4210654835, https://openalex.org/W6799699912, https://openalex.org/W4300963246, https://openalex.org/W3138369770, https://openalex.org/W3173737570, https://openalex.org/W4221038042, https://openalex.org/W3085259011, https://openalex.org/W3028115799, https://openalex.org/W6792804328, https://openalex.org/W2996668879, https://openalex.org/W3167334836, https://openalex.org/W2006236530, https://openalex.org/W3193704441, https://openalex.org/W2405183840, https://openalex.org/W4206903450, https://openalex.org/W4200621709, https://openalex.org/W3213860013, https://openalex.org/W3090724433, https://openalex.org/W4226276968, https://openalex.org/W4206083502, https://openalex.org/W1574141134, https://openalex.org/W3142113446
referenced_works_count	44
abstract_inverted_index
cited_by_percentile_year.max	98
cited_by_percentile_year.min	97
corresponding_author_ids	https://openalex.org/A5100322813
countries_distinct_count	1
institutions_distinct_count	6
corresponding_institution_ids	https://openalex.org/I4210150756
sustainable_development_goals[0].id	https://metadata.un.org/sdg/8
sustainable_development_goals[0].score	0.41999998688697815
sustainable_development_goals[0].display_name	Decent work and economic growth
citation_normalized_percentile.value	0.81752596
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False